XTR-003

N/A

Report date: 2025/09/09 15:00:24

NME

Base Information

Drug NameXTR-003

Drug Alias Name新型18F-标记心肌脂肪酸代谢PET显像剂XTR003注射液XTR-003

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionPositron-emission tomography enhancers

TargetsNot applicable

Therapy Area/IndicationsContrast agentsCoronary Artery DiseaseMyocardial Ischemia +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesBeijing Xiantong International Technology Co Ltd

China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBeijing Xiantong International Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsContrast agentsCoronary Artery DiseaseMyocardial Ischemia +[4]

Inactive IndicationsN/A

Other Information

ATC CodeN/A